{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:25:17Z","timestamp":1783527917971,"version":"3.55.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006315","name":"Reumafonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00312","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:04:40Z","timestamp":1551164680000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Fatigue in Sj\u00f6gren's Syndrome: A Search for Biomarkers and Treatment Targets"],"prefix":"10.3389","volume":"10","author":[{"given":"Iris L. A.","family":"Bodewes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"van der Spek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia G.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie J. M.","family":"Wijkhuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia G.","family":"van Helden-Meeuwsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselotte","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco W. J.","family":"Schreurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L. A.","family":"van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Katsikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan A.","family":"Versnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0049-0172(84)90001-5","article-title":"Primary sjogren syndrome: clinical and immunopathologic features","volume":"14","author":"Fox","year":"1984","journal-title":"Semin Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2796.1996.418817000.x","article-title":"A new model for classification of disease manifestations in primary Sj\u00f6gren's syndrome: evaluation in a retrospective long-term study","volume":"239","author":"Asmussen","year":"1996","journal-title":"J Intern Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/art.21990","article-title":"Quality of life and psychological status in patients with primary Sj\u00f6gren's syndrome and sicca symptoms without autoimmune features","volume":"55","author":"Champey","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/art.24311","article-title":"Prevalence, severity and predictors of fatigue in primary sjogren's syndrome","volume":"59","author":"Segal","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3487","article-title":"A five-year prospective study of fatigue in primary Sj\u00f6gren's syndrome","volume":"13","author":"Haldorsen","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/rheumatology\/keq023","article-title":"Sleepiness or fatigue? can we detect treatable causes of tiredness in primary Sj\u00f6gren's syndrome?","volume":"49","author":"Theander","year":"2010","journal-title":"Rheumatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/acr.22720","article-title":"Fatigue in primary Sj\u00f6gren's syndrome: clinical, laboratory, psychometric, and biologic associations","volume":"68","author":"Karageorgas","year":"2016","journal-title":"Arthritis Care Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10067-015-3035-6","article-title":"The prevalence of severe fatigue in rheumatic diseases: an international study","volume":"35","author":"Overman","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0091-7435(86)90037-X","article-title":"The epidemiology of self-perceived fatigue among adults","volume":"15","author":"Chen","year":"1986","journal-title":"Prev Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0022-3999(97)00291-2","article-title":"Fatigue in the general norwegian population: normative data and associations","volume":"45","author":"Loge","year":"1998","journal-title":"J Psychosom Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14034940410028406","article-title":"Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale","volume":"33","author":"Lerdal","year":"2005","journal-title":"Scand J Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e000282","DOI":"10.1136\/rmdopen-2016-000282","article-title":"Fatigue in primary Sj\u00f6gren's syndrome is associated with lower levels of proinflammatory cytokines","volume":"2","author":"Howard Tripp","year":"2016","journal-title":"RMD Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/eji.200738008","article-title":"Systemic increase in type I interferon activity in Sj\u00f6gren's syndrome: a putative role for plasmacytoid dendritic cells","volume":"38","author":"Wildenberg","year":"2008","journal-title":"Eur J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj\u00f6gren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/art.21006","article-title":"Gene expression profiling of minor salivary glands clearly distinguishes primary Sj\u00f6gren's syndrome patients from healthy control subjects","volume":"52","author":"Hjelmervik","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes Immun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","article-title":"Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren's syndrome reveals regulatory effects at interferon-induced genes","volume":"75","author":"Imgenberg-Kreuz","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2013\/471703","article-title":"Rare Variants in the TREX1 Gene and susceptibility to autoimmune diseases","volume":"2013","author":"Barizzone","year":"2013","journal-title":"Biomed Res Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1002\/art.23142","article-title":"Association of an IRF5 gene functional polymorphism with Sj\u00f6gren's syndrome","volume":"56","author":"Miceli-Richard","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sj\u00f6gren's syndrome","volume":"10","author":"Nordmark","year":"2008","journal-title":"Genes Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/art.24662","article-title":"The CGGGG insertion\/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sj\u00f6gren's syndrome","volume":"60","author":"Miceli-Richard","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/gene.2008.1","article-title":"Variant form of STAT4 is associated with primary Sj\u00f6gren's syndrome","volume":"9","author":"Korman","year":"2008","journal-title":"Genes Immun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/gene.2010.29","article-title":"STAT4 is a confirmed genetic risk factor for Sj\u00f6gren's syndrome and could be involved in type 1 interferon pathway signaling","volume":"11","author":"Gestermann","year":"2010","journal-title":"Genes Immun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clim.2016.10.015","article-title":"Increased frequency of the PTPN22W* variant in primary Sjogren's syndrome: association with low type I IFN scores","volume":"173","author":"Vlachogiannis","year":"2016","journal-title":"Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis","volume":"73","author":"Udina","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1200\/JCO.2008.20.2069","article-title":"Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European organisation for research and treatment of cancer melanoma group","volume":"27","author":"Andrew","year":"2009","journal-title":"J Clin Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/rheumatology\/kex490","article-title":"Systemic interferon type I and type II signatures in primary Sj\u00f6gren's syndrome reveal differences in biological disease activity","volume":"57","author":"Bodewes","year":"2018","journal-title":"Rheumatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1002\/art.20798","article-title":"Coordinate overexpression of interferon-\u03b1-induced genes in systemic lupus erythematosus","volume":"50","author":"Kirou","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B33","doi-asserted-by":"publisher","first-page":"19971","DOI":"10.1073\/pnas.1213933109","article-title":"Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets","volume":"109","author":"Davies","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1038\/mtna.2014.49","article-title":"Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents","volume":"3","author":"Rohloff","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"B35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1023\/A:1016673003237","article-title":"The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects","volume":"9","author":"Schroevers","year":"2000","journal-title":"Qual Life Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jprot.2016.08.023","article-title":"Complementarity of SOMAscan to LC-MS\/MS and RNA-seq for quantitative profiling of human embryonic and mesenchymal stem cells","volume":"150","author":"Billing","year":"2017","journal-title":"J Proteomics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology","volume":"10","author":"Sattlecker","year":"2014","journal-title":"Alzheimer's Dement."},{"key":"B40","doi-asserted-by":"publisher","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/14789450.2017.1333904","article-title":"Updates on Sj\u00f6gren's syndrome: from proteomics to protein biomarkers","volume":"14","author":"Baldini","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1111\/sji.12662","article-title":"Transcription profiling of peripheral B cells in antibody-positive primary Sj\u00f6gren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature","volume":"87","author":"Imgenberg-Kreuz","year":"2018","journal-title":"Scand J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.humimm.2013.09.012","article-title":"Meta-analysis of differentially expressed genes in primary Sjogren's syndrome by using microarray","volume":"75","author":"Song","year":"2014","journal-title":"Hum Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13075-016-1006-1","article-title":"Identification of definitive serum biomarkers associated with disease activity in primary Sj\u00f6gren's syndrome","volume":"18","author":"Nishikawa","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0143970","DOI":"10.1371\/journal.pone.0143970","article-title":"A transcriptional signature of fatigue derived from patients with primary Sj\u00f6gren's syndrome","volume":"10","author":"James","year":"2015","journal-title":"PLoS ONE"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.18632\/oncotarget.22814","article-title":"IL-36 cytokines in autoimmunity and inflammatory disease","volume":"9","author":"Ding","year":"2018","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/cei.12644","article-title":"Interleukin-36\u03b1 axis is modulated in patients with primary Sj\u00f6gren's syndrome","volume":"181","author":"Ciccia","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36\u03b1 is expressed in psoriatic and rheumatoid arthritis synovium","volume":"72","author":"Frey","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B49","first-page":"89","article-title":"Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia","volume":"34","author":"Jones","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary Sj\u00f6gren's syndrome","volume":"41","author":"Solans-Laqu,\u00e9","year":"2011","journal-title":"Semin Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1126\/science.1084909","article-title":"Fusion of cells by flipped SNAREs","volume":"300","author":"Hu","year":"2003","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2474-15-191","article-title":"Synaptosomal-associated protein 25 (Snap-25) gene polymorphism frequency in fibromyalgia syndrome and relationship with clinical symptoms","volume":"15","author":"Balkarli","year":"2014","journal-title":"BMC Musculoskelet Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.2008.03995.x","article-title":"SNAP-25 in neuropsychiatric disorders","volume":"1152","author":"Corradini","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1750-1326-9-53","article-title":"SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease","volume":"9","author":"Brinkmalm","year":"2014","journal-title":"Mol Neurodegener."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1093\/cercor\/bhu318","article-title":"Corticospinal motor neurons are susceptible to increased ER stress and display profound degeneration in the absence of UCHL1 function","volume":"25","author":"Jara","year":"2015","journal-title":"Cereb Cortex"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e34713","DOI":"10.1371\/journal.pone.0034713","article-title":"Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy","volume":"7","author":"Cartier","year":"2012","journal-title":"PLoS ONE"},{"key":"B58","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0166-2236(98)01276-4","article-title":"Ubiquitin, cellular inclusions and their role in neurodegeneration","volume":"21","author":"Alves-Rodrigues","year":"1998","journal-title":"Trends Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/35086067","article-title":"Failure of the ubiquitin\u2013proteasome system in Parkinson's disease","volume":"2","author":"Mcnaught","year":"2001","journal-title":"Nat Rev Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.aninu.2016.02.005","article-title":"Progress in the biological function of alpha-enolase","volume":"2","author":"Ji","year":"2016","journal-title":"Anim Nutr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1002\/art.23936","article-title":"Antibodies to citrullinated \u03b1-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase","volume":"58","author":"Lundberg","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2011\/870214","article-title":"Anti\u2013enolase antibodies in serum from pediatric patients affected by inflammatory diseases: diagnostic and pathogenetic insights","volume":"2011","author":"Pontillo","year":"2011","journal-title":"Int J Rheumatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneuroim.2007.01.018","article-title":"High prevalence of serum autoantibodies against the amino terminal of \u03b1-enolase in Hashimoto's encephalopathy","volume":"185","author":"Yoneda","year":"2007","journal-title":"J Neuroimmunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human \u03b1-enolase from endothelial cells as a target antigen of anti\u2013endothelial cell antibody in Beh\u00e7et's disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1546-0096-11-31","article-title":"Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis","volume":"11","author":"Gilliam","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2017.09.012","article-title":"Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome","volume":"183","author":"Nezos","year":"2017","journal-title":"Clin Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0002-9394(03)00203-4","article-title":"Abnormal protein profiles in tears with dry eye syndrome","volume":"136","author":"Ohashi","year":"2003","journal-title":"Am J Ophthalmol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/03009742.2015.1072243","article-title":"Diminished salivary epidermal growth factor secretion: a link between Sj\u00f6gren's syndrome and autoimmune gastritis?","volume":"45","author":"Koskenpato","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"B69","first-page":"1930","article-title":"Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sj\u00f6gren's syndrome","volume":"24","author":"Koski","year":"1997","journal-title":"J Rheumatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3109\/14397595.2013.850766","article-title":"Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sj\u00f6gren's syndrome","volume":"24","author":"Azuma","year":"2014","journal-title":"Mod Rheumatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3109\/14397595.2015.1034941","article-title":"Rapid decrease in salivary epidermal growth factor levels in patients with Sj\u00f6gren's syndrome: a 3-year follow-up study","volume":"25","author":"Azuma","year":"2015","journal-title":"Mod Rheumatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1037\/neu0000470","article-title":"A Functional Promoter Variant of the Human Formimidoyltransferase Cyclodeaminase (FTCD) gene is associated with working memory performance in young but not older adults","volume":"32","author":"Greenwood","year":"2018","journal-title":"Neuropsychology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/annrheumdis-2017-eular.3973","article-title":"OP0312 a proteomic signature of fatigue in primary Sj\u00f6gren's syndrome","volume":"76","author":"Omdal","year":"2017","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:04:47Z","timestamp":1551164687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2019.00312"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00312","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"article-number":"312"}}